School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Mitsi Blount PhD

  • Department of Medicine
    Adjunct Assistant Professor
  • (404) 712-1188
  • mabloun@emory.edu
Head shot of Mitsi Blount

Overview

Dr. Blount graduated in 1999 with a BS in biology from the University of North Carolina at Chapel Hill. She earned her PhD in molecular physiology and biophysics at Vanderbilt University School of Medicine in 2005. She was a postdoctoral fellow at Emory University School of Medicine from 2005-2008. Currently, Dr. Blount is a tenure-track assistant professor of medicine in the Department of Medicine's Division of Renal Medicine.

RESEARCH
Intracellular cAMP levels within kidney cells are increased in response to a variety of hormonal and chemical stimuli, including vasopressin. Vasopressin, a hormone released from the pituitary when the body is dehydrated, signals the kidneys to conserve water in order to maintain the bodys water balance. In the inner medullary collecting duct (IMCD), vasopressin increases water permeability allowing for water reabsorption from the tubule lumen thus setting the stage for the production of concentrated urine. Vasopressin binds to the V2 receptor located on the basolateral membrane of the IMCD, activates Gs, which in turn stimulates adenylyl cyclase to synthesize cAMP. The second messenger cAMP has many downstream targets including, 1) cAMP-dependent protein kinase (PKA) and 2) several cAMP-specific phosphodiesterases (PDEs). The exact vasopressin-stimulated cAMP signaling cascade resulting in urine concentration has not been elucidated. Many of the transporters that contribute to urine concentration are in some way mediated by cAMP. One of these transporters is the urea transporter, UT-A1. Our laboratory investigates the many cAMP-mediated processes that regulate UT-A1 function including how vasopressin-stimulated phosphorylation of UT-A1 by PKA effects transporter trafficking and activity. Elucidating the signaling cascades triggered by vasopressin in the IMCD will not only provide new insight into urea handling but may also be beneficial in understanding the mechanisms underlying the disregulation of water homeostasis that occurs in common clinical disorders, such as congestive heart failure, cirrhosis, and nephrotic syndrome.

Academic Appointment

  • Assistant Professor, Department of Physiology
  • Assistant Professor, Department of Medicine

Education

Degrees

  • PhD from Vanderbilt University School of Medicine
  • High School from Scotland County High School
  • BS from University of North Carolina

Research

Publications

  • Purinergic signaling is enhanced in the absence of UT-A1 and UT-A3.
    Physiol Rep Volume: 9 Page(s): e14636
    01/01/2021 Authors: Himmel NJ; Rogers RT; Redd SK; Wang Y; Blount MA
  • Lack of urea transporters, UT-A1 and UT-A3, increases nitric oxide accumulation to dampen medullary sodium reabsorption through ENaC.
    Volume: 316 Page(s): F539 - F549
    03/01/2019 Authors: Rogers RT; Sun MA; Yue Q; Bao H-F; Sands JM; Blount MA; Eaton DC
  • Chronic lithium treatment induces novel patterns of pendrin localization and expression.
    Volume: 315 Page(s): F313 - F322
    08/01/2018 Authors: Himmel NJ; Wang Y; Rodriguez DA; Sun MA; Blount MA
  • Dual PDE3/4 Inhibition Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus
    Volume: 31
    04/01/2017 Authors: Borchart MA; Gumina DL; Kronk TA; Sim JH; Blount MA
  • Inhibition of PDE7 Reduces Inflammatory Response Following Renal Ischemia/Reperfusion Injury
    Volume: 31
    04/01/2017 Authors: Reis WR; Sun MA; Kronk TA; Blount MA
  • Polyphenolics Protect Renal Fibroblasts from the Harmful Effects of Hyperglycemia-Stimulated Advanced Glycation End Products
    Volume: 31
    04/01/2017 Authors: Harris JM; Blount MA
  • Lithium Administration Can Attenuate the Progression of Polycystic Kidney Disease
    Volume: 31
    04/01/2017 Authors: Kronk TA; Himmel NJ; Mehran NA; Blount MA
  • Metformin, an AMPK activator, stimulates the phosphorylation of aquaporin 2 and urea transporter A1 in inner medullary collecting ducts.
    Am J Physiol Renal Physiol Volume: 310 Page(s): F1008 - F1012
    05/15/2016 Authors: Klein JD; Wang Y; Blount MA; Molina PA; LaRocque LM; Ruiz JA; Sands JM
  • Transgenic Restoration of Urea Transporter A1 Confers Maximal Urinary Concentration in the Absence of Urea Transporter A3.
    J Am Soc Nephrol Volume: 27 Page(s): 1448 - 1455
    05/01/2016 Authors: Klein JD; Wang Y; Mistry A; LaRocque LM; Molina PA; Rogers RT; Blount MA; Sands JM
  • Absence of PKC alpha Alters the Renal Immune Response in Angiotensin II-dependent Hypertension
    Volume: 30
    04/01/2016 Authors: Borchart MR; Pulous FE; Wang Y; Sun MA; Himmel NJ; Vanderford TH; Blount MA
  • Lithium Modulates Cilia Length in Renal Collecting Duct Cells
    Volume: 30
    04/01/2016 Authors: Mehran NA; Mallow JF; Himmel NJ; Blount MA
  • Ablation of the Renal Urea Transporters UT-A1 and UT-A3 Replicates the Benefits of a Low-protein Diet in Attenuating Diabetic Nephropathy
    Volume: 30
    04/01/2016 Authors: Wang Y; Himmel NJ; Mallow GM; Sun MA; Borchart MR; Blount MA
  • Activation of protein kinase C increases phosphorylation of the UT-A1 urea transporter at serine 494 in the inner medullary collecting duct.
    Am J Physiol Cell Physiol Volume: 309 Page(s): C608 - C615
    11/01/2015 Authors: Blount MA; Cipriani P; Redd SK; Ordas RJ; Black LN; Gumina DL; Hoban CA; Klein JD; Sands JM
  • Lithium Potentiates Epithelial-Mesenchymal Transition in the Kidney through Induction of Matrix Metallopeptidase-9
    Volume: 29
    04/01/2015 Authors: Ward J; Swaim G; Gooch J; Blount M
  • Smooth Muscle-Targeted Overexpression of Peroxisome Proliferator Activated Receptor- Disrupts Vascular Wall Structure and Function.
    PLoS One Volume: 10 Page(s): e0139756
    01/01/2015 Authors: Kleinhenz JM; Murphy TC; Pokutta-Paskaleva AP; Gleason RL; Lyle AN; Taylor WR; Blount MA; Cheng J; Yang Q; Sutliff RL
  • Vasopressin regulation of multisite phosphorylation of UT-A1 in the inner medullary collecting duct.
    Am J Physiol Renal Physiol Volume: 308 Page(s): F49 - F55
    01/01/2015 Authors: Hoban CA; Black LN; Ordas RJ; Gumina DL; Pulous FE; Sim JH; Sands JM; Blount MA
  • Novel activators of aquaporin 2 membrane expression for the treatment of nephrogenic diabetes insipidus: less is more. Focus on "High-throughput chemical screening identifies AG-490 as a stimulator of aquaporin 2 membrane expression and urine concentration".
    Am J Physiol Cell Physiol Volume: 307 Page(s): C595 - C596
    10/01/2014 Authors: Sands JM; Blount MA
  • Purinergic signaling is enhanced in the absence of UT-A1 and UT-A3
    FASEB JOURNAL Volume: 28
    04/01/2014 Authors: Rogers R; Himmei N; Redd S; Blount M
  • miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export.
    Am J Physiol Cell Physiol Volume: 306 Page(s): C551 - C558
    03/15/2014 Authors: Hudson MB; Woodworth-Hobbs ME; Zheng B; Rahnert JA; Blount MA; Gooch JL; Searles CD; Price SR
  • Lack of an effect of collecting duct-specific deletion of adenylyl cyclase 3 on renal Na+ and water excretion or arterial pressure.
    Am J Physiol Renal Physiol Volume: 306 Page(s): F597 - F607
    03/15/2014 Authors: Kittikulsuth W; Stuart D; Van Hoek AN; Stockand JD; Bugaj V; Mironova E; Blount MA; Kohan DE
  • Genes and proteins of urea transporters.
    Subcell Biochem Volume: 73 Page(s): 45 - 63
    01/01/2014 Authors: Sands JM; Blount MA
  • Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.
    PLoS One Volume: 9 Page(s): e101753
    01/01/2014 Authors: Sim JH; Himmel NJ; Redd SK; Pulous FE; Rogers RT; Black LN; Hong SM; von Bergen TN; Blount MA
  • Carl W. Gottschalk Distinguished Lecturer of the American Physiological Society Renal Section.
    Am J Physiol Renal Physiol
    02/13/2013 Authors: Blount MA
  • Urine concentration in the diabetic mouse requires both urea and water transporters.
    Am J Physiol Renal Physiol Volume: 304 Page(s): F103 - F111
    01/01/2013 Authors: Ilori TO; Blount MA; Martin CF; Sands JM; Klein JD
  • Molecular mechanisms of urea transport in health and disease.
    Pflugers Arch Volume: 464 Page(s): 561 - 572
    12/01/2012 Authors: Klein JD; Blount MA; Sands JM
  • Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla.
    Am J Physiol Renal Physiol Volume: 303 Page(s): F900 - F905
    09/15/2012 Authors: von Bergen TN; Blount MA
  • Lack of protein kinase C- leads to impaired urine concentrating ability and decreased aquaporin-2 in angiotensin II-induced hypertension.
    Am J Physiol Renal Physiol Volume: 303 Page(s): F37 - F44
    07/01/2012 Authors: Thai TL; Blount MA; Klein JD; Sands JM
  • Acute calcineurin inhibition with tacrolimus increases phosphorylated UT-A1.
    Am J Physiol Renal Physiol Volume: 302 Page(s): F998 - F1004
    04/15/2012 Authors: Ilori TO; Wang Y; Blount MA; Martin CF; Sands JM; Klein JD
  • The urea transporter UT-A1 is phosphorylated at serines 486 and 499 downstream of cyclic AMP production
    Volume: 26
    04/01/2012 Authors: Thai TL; Gumina DL; Ilori TO; Klein JD; Blount MA; Sands JM
  • The role of nitric oxide in the dysregulation of the urine concentration mechanism in diabetes mellitus.
    Front Physiol Volume: 3 Page(s): 176
    01/01/2012 Authors: Cipriani P; Kim SL; Klein JD; Sim JH; von Bergen TN; Blount MA
  • Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice.
    Am J Physiol Renal Physiol Volume: 302 Page(s): F78 - F84
    01/01/2012 Authors: Roos KP; Strait KA; Raphael KL; Blount MA; Kohan DE
  • ACUTE CALCINEURIN INHIBITION WITH TACROLIMUS INCREASES PHOSPHORYLATION OF UT-A1 AT SERINE 486
    Volume: 60 Page(s): 385 - 385
    01/01/2012 Authors: Ilori TO; Wang Y; Blount MA; Sands J; Klein JD
  • LACK OF PROTEIN KINASE C alpha LEADS TO IMPAIRED URINE CONCENTRATING ABILITY AND DECREASED AQUAPORIN-2 IN ANGIOTENSIN II-INDUCED HYPERTENSION
    Volume: 60 Page(s): 425 - 425
    01/01/2012 Authors: Thai TL; Blount MA; Klein JD; Sands JM
  • Metal ion stimulators of PDE5 cause similar conformational changes in the enzyme as does cGMP or sildenafil.
    Cell Signal Volume: 23 Page(s): 778 - 784
    05/01/2011 Authors: Corbin JD; Foster T-L; Bessay E; Busch J; Blount M; Francis SH
  • Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
    Physiol Rev Volume: 91 Page(s): 651 - 690
    04/01/2011 Authors: Francis SH; Blount MA; Corbin JD
  • Phosphorylation of UT-A1 at S486 and S499 is a Rapid and Non-Redundant Response to Increased Intercellular cAMP
    Volume: 25
    04/01/2011 Authors: Blount MA; Hoban CA; Gumina DL; Klein JD; Sands JM
  • The Urea Transporter UT-A1 is Directly Phosphorylated by PKC
    Volume: 25
    04/01/2011 Authors: Redd SK; Cipriani P; Ordas R; Klein JD; Blount MA; Sands JM
  • Urea transport in the kidney.
    Compr Physiol Volume: 1 Page(s): 699 - 729
    04/01/2011 Authors: Klein JD; Blount MA; Sands JM
  • MEMBRANE ACCUMULATION OF THE UREA TRANSPORTER IN THE DIABETIC RAT KIDNEY
    Volume: 59 Page(s): 461 - 462
    02/01/2011 Authors: Ilori TO; Thai T; Martin C; Blount MA; Sands JM; Klein JD
  • Regulation of renal urea transport by vasopressin.
    Trans Am Clin Climatol Assoc Volume: 122 Page(s): 82 - 92
    01/01/2011 Authors: Sands JM; Blount MA; Klein JD
  • A timely characterization of vasopressin-sensitive adenylyl cyclase isoforms in the mouse inner medullary collecting duct.
    Am J Physiol Renal Physiol Volume: 298 Page(s): F857 - F858
    04/01/2010 Authors: Blount MA
  • The Role of Nitric Oxide in the Urine Concentration Mechanism in Diabetic Rats
    FASEB JOURNAL Volume: 24
    04/01/2010 Authors: Cipriani P; Kim SL; Klein JD; Denson CE; Sim JH; Sands JM; Blount MA
  • Phosphorylation of UT-A1 on serine 486 correlates with membrane accumulation and urea transport activity in both rat IMCDs and cultured cells.
    Am J Physiol Renal Physiol Volume: 298 Page(s): F935 - F940
    04/01/2010 Authors: Klein JD; Blount MA; Frhlich O; Denson CE; Tan X; Sim JH; Martin CF; Sands JM
  • Expression of transporters involved in urine concentration recovers differently after cessation of lithium treatment.
    Am J Physiol Renal Physiol Volume: 298 Page(s): F601 - F608
    03/01/2010 Authors: Blount MA; Sim JH; Zhou R; Martin CF; Lu W; Sands JM; Klein JD
  • THE ROLE OF NITRIC OXIDE IN THE URINE CONCENTRATION MECHANISM IN DIABETIC RATS
    Volume: 58 Page(s): 427 - 427
    02/01/2010 Authors: Cipriani P; Kim SL; Klein JD; Denson CE; Sim JH; Sands JM; Blount MA
  • Epac regulates UT-A1 to increase urea transport in inner medullary collecting ducts.
    J Am Soc Nephrol Volume: 20 Page(s): 2018 - 2024
    09/01/2009 Authors: Wang Y; Klein JD; Blount MA; Martin CF; Kent KJ; Pech V; Wall SM; Sands JM
  • Urea transporters UT-A1 and UT-A3 accumulate in the plasma membrane in response to increased hypertonicity.
    Am J Physiol Renal Physiol Volume: 295 Page(s): F1336 - F1341
    11/01/2008 Authors: Blessing NW; Blount MA; Sands JM; Martin CF; Klein JD
  • Phosphorylation of the UT-A1 by PKA at serines 486 and 499 is important to vasopressin regulation of urea transport
    Volume: 52 Page(s): E70 - E70
    10/01/2008 Authors: Blount MA; Mistry AC; Froehlich O; Chen G; Sands JM; Klein JD
  • Phosphorylation of UT-A1 urea transporter at serines 486 and 499 is important for vasopressin-regulated activity and membrane accumulation.
    Am J Physiol Renal Physiol Volume: 295 Page(s): F295 - F299
    07/01/2008 Authors: Blount MA; Mistry AC; Frhlich O; Price SR; Chen G; Sands JM; Klein JD
  • Candesartan augments compensatory changes in medullary transport proteins in the diabetic rat kidney.
    Am J Physiol Renal Physiol Volume: 294 Page(s): F1448 - F1452
    06/01/2008 Authors: Blount MA; Sands JM; Kent KJ; Smith TD; Price SR; Klein JD
  • Phosphorylation increases affinity of the phosphodiesterase-5 catalytic site for tadalafil.
    J Pharmacol Exp Ther Volume: 325 Page(s): 62 - 68
    04/01/2008 Authors: Bessay EP; Blount MA; Zoraghi R; Beasley A; Grimes KA; Francis SH; Corbin JD
  • AVP causes transient formation of cAMP and activation of phosphodiesterase activity in MDCK cells
    FASEB JOURNAL Volume: 22
    04/01/2008 Authors: Froehlich O; Blount MA; Yang Y; Klein JD; Sands JM
  • Transport proteins in the inner medullas of diabetic kidneys are further increased by candesartan
    FASEB JOURNAL Volume: 22
    04/01/2008 Authors: Blount MA; Sands JM; Kent KJ; Smith TD; Klein JD
  • Candesartan augments the compensatory changes in medullary transport proteins in the diabetic rat kidney
    Volume: 56 Page(s): 452 - 452
    01/01/2008 Authors: Blount MA; Sands JM; Kent KJ; Smith TD; Klein JD
  • Conversion of phosphodiesterase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors.
    J Pharmacol Exp Ther Volume: 323 Page(s): 730 - 737
    11/01/2007 Authors: Blount MA; Zoraghi R; Bessay EP; Beasley A; Francis SH; Corbin JD
  • Forskolin stimulates phosphorylation and membrane accumulation of UT-A3.
    Am J Physiol Renal Physiol Volume: 293 Page(s): F1308 - F1313
    10/01/2007 Authors: Blount MA; Klein JD; Martin CF; Tchapyjnikov D; Sands JM
  • UT-A3: is it an apical or basolateral membrane urea transporter?
    Volume: 21 Page(s): A906 - A907
    04/01/2007 Authors: Blount MA; Sands JM; Martin CF; Klein JD
  • Phosphorylation of phosphodiesterase-5 is promoted by a conformational change induced by sildenafil, vardenafil, or tadalafil.
    Front Biosci Volume: 12 Page(s): 1899 - 1910
    01/01/2007 Authors: Bessay EP; Zoraghi R; Blount MA; Grimes KA; Beasley A; Francis SH; Corbin JD
  • A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Mol Pharmacol Volume: 70 Page(s): 1822 - 1831
    11/01/2006 Authors: Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
  • Vasopressin increases plasma membrane accumulation of urea transporter UT-A1 in rat inner medullary collecting ducts.
    J Am Soc Nephrol Volume: 17 Page(s): 2680 - 2686
    10/01/2006 Authors: Klein JD; Frhlich O; Blount MA; Martin CF; Smith TD; Sands JM
  • Multiple kinetic forms of phosophodiesterase-5 (PDE5) are interconvertible in a regulatory domain-dependent manner
    Volume: 20 Page(s): A543 - A543
    03/06/2006 Authors: Blount MA; Zoraghi R; Bessay EP; Frames SH; Corbin JD
  • Potent inhibition of phosphodiesterase-5 (PDE5) by vardenafil, but not by sildenafil, tadalafil, or IBMX requires an intact GAF b domain
    Volume: 20 Page(s): A543 - A543
    03/06/2006 Authors: Blount MA; Zoraghi R; Corbin JD; Francis SH
  • High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors.
    Biochem Biophys Res Commun Volume: 334 Page(s): 930 - 938
    09/02/2005 Authors: Corbin JD; Beasley A; Blount MA; Francis SH
  • Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters.
    Front Biosci Volume: 10 Page(s): 2097 - 2117
    09/01/2005 Authors: Francis SH; Blount MA; Zoraghi R; Corbin JD
  • Radiolabeled ligand binding to the catalytic or allosteric sites of PDE5 and PDE11.
    Methods Mol Biol Volume: 307 Page(s): 239 - 262
    01/01/2005 Authors: Weeks JL; Blount MA; Beasley A; Zoraghi R; Thomas MK; Sekhar KR; Corbin JD; Francis SH
  • Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5).
    Volume: 45 Page(s): 859 - 863
    11/01/2004 Authors: Corbin JD; Beasley A; Blount MA; Francis SH
  • Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
    Mol Pharmacol Volume: 66 Page(s): 144 - 152
    07/01/2004 Authors: Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
  • Allosteric sites of phosphodiesterase-5 sequester cyclic GMP.
    Front Biosci Volume: 9 Page(s): 378 - 386
    01/01/2004 Authors: Kotera J; Francis SH; Grimes KA; Rouse A; Blount MA; Corbin JD
  • [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
    Mol Pharmacol Volume: 63 Page(s): 1364 - 1372
    06/01/2003 Authors: Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YSJ; Saidi LF; Hurley JH; Kotera J; Francis SH
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements